by Shitika Kulshreshtha | Jan 9, 2026 | News Releases
In Response to OSC Requirements to Explain EBITDA (a non-IFRS measure) MISSISSAUGA, CANADA, January 9, 2026 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that it has...
by Shitika Kulshreshtha | Jan 7, 2026 | News Releases
For Usage in QAPs and Test Manufacturing MISSISSAUGA, CANADA, January 7, 2026 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces the commercial usage of its first recombinant antigen...
by Shitika Kulshreshtha | Dec 18, 2025 | News Releases
Full-Year Revenues of $18.6 million and Net Loss of $2.2 million MISSISSAUGA, CANADA, December 18, 2025 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, reports results for its fiscal... by Shitika Kulshreshtha | Dec 11, 2025 | News Releases
Results Release and Webinar Discussion on Morning of December 18, 2025 MISSISSAUGA, CANADA, December 11, 2025 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that it expects...
by Shitika Kulshreshtha | Dec 10, 2025 | News Releases
Test-Controls & Reference Materials for Labs & Test-Makers MISSISSAUGA, CANADA, December 10, 2025 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces the commercial launch of...